denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Prothena, Janssen and Alexion
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Education, Diseases, Treatment Considerations, Adverse Events
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Education, Diseases, Treatment Considerations, Adverse Events
Friday, December 6, 2024: 11:00 AM-2:00 PM
Marriott Grand Ballroom 8-9
(Marriott Marquis San Diego Marina)
Chair:
Morie A. Gertz, MD, Mayo Clinic
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Suzanne Lentzsch, MD, PhD, Columbia University Herbert Irving Comprehensive Cancer Center
and
Vaishali Sanchorawala, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center
Disclosures:
Lentzsch: Zentalis: Research Funding; Sanofi: Other: Advisory Board, Research Funding; Medscape: Honoraria; Bio Ascend: Honoraria; RedMed: Honoraria; Clinical Care Options (CCO): Honoraria; PeerView: Honoraria; Takeda: Other: Advisory Board; Karyopharm: Other: Advisory Board; BMS: Membership on an entity's Board of Directors or advisory committees; Sanofi: Other: Advisory Board, Research Funding; GSK: Other: Advisory Board; Janssen: Membership on an entity's Board of Directors or advisory committees; Regeneron: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Pfizer: Other: Advisory Board; Caelum Bioscience: Patents & Royalties: CAEL-101. Sanchorawala: Proclara, Caelum, Abbvie, Janssen, Regeneron, Protego, Pharmatrace, Telix, Prothena, AstraZeneca, Nexcella: Membership on an entity's Board of Directors or advisory committees; Pfizer, Janssen, Attralus, GateBio, Abbvie, BridgeBio: Consultancy; Celgene, Millennium-Takeda, Janssen, Prothena, Sorrento, Karyopharm, Oncopeptide, Caelum, Alexion: Research Funding.
On Demand program will be available here December 21, 2024.
This 90-minute symposium will feature 3 multidisciplinary expert faculty. The symposium is designed to engage attendees in an interactive experience focused on key challenges and therapeutic advances in the management of AL amyloidosis. The overall goal of this symposium is for learners to be better able to integrate evidence-based strategies for the optimal care of patients with AL amyloidosis.
See more of: Friday Satellite Symposia